focus -WSS

focus

author：fashion 2025-09-30 00:39:51 - browse：56317

New Sanofi Genzyme president Bill Sibold is the first person without any ties to Henri Termeer (inset) to lead the company. Jonathan Wiggs/Globe staff

CAMBRIDGE, Mass. — When drug giant Sanofi restructured its global business two years ago, its Genzyme division got a new name, Sanofi Genzyme, explicitly tying it to the French parent company. It also got new responsibilities and a larger “specialty care” portfolio covering everything from enzyme replacement to cancer and multiple sclerosis drugs.

Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold. He’s the first one without any ties to the old Genzyme, an independent company that pioneered the rare-disease business model and catalyzed the local life sciences boom before accepting Sanofi’s $20.1 billion takeover offer in 2011.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Caregivers of transplant patients call for more support, training

WSS

The new HIV moral panic

Idaho abortion case may prompt more restrictions in other states

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Involuntary treatment for addiction doesn't work

Europe sees delivery challenges ahead on Alzheimer's therapies

The SUPPORT Act is critical to fighting the opioid crisis

knowledge

focus

Wikipedia

What does generative AI mean for health care? We asked experts

Idaho abortion case may prompt more restrictions in other states

Bright Health sells Medicare Advantage business to Molina

The nurse manager staffing crisis is hurting patients

ChatGPT in medicine: STAT answers readers' burning questions

Georgia court denies Trump's request to quash DA's 2020 election probe

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

HHS names first

After affirmative action ruling, medical educators look to 'holistic review'

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

focus

HHS names first

Georgia court denies Trump's request to quash DA's 2020 election probe

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Congress likely to miss an opportunity to fix drug shortages issue

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Global childhood vaccinations edge closer to pre

leisure time

Wikipedia

explore

leisure time